Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticaria von Magerl, M., Rother, M., Bieber, T., Biedermann, T., Brasch, J., Dominicus, R., Hunzelmann, N., Jakob, T., Mahler, V., Popp, G., Schäkel, K., Schlingensiepen, R., Schmitt, J., Siebenhaar, F., Simon, J.C., Staubach, P., Wedi, B., Weidner, C., Maurer, M.

Volltext

Targeted tumor therapy with the TGF-β2 antisense compound AP 12009 von Schlingensiepen, Karl-Hermann, Schlingensiepen, Reimar, Steinbrecher, Andreas, Hau, Peter, Bogdahn, Ulrich, Fischer-Blass, Birgit, Jachimczak, Piotr

Volltext

Targeted tumor therapy with the TGF-beta 2 antisense compound AP 12009 von Schlingensiepen, Karl-Hermann, Schlingensiepen, Reimar, Steinbrecher, Andreas, Hau, Peter, Bogdahn, Ulrich, Fischer-Blass, Birgit, Jachimczak, Piotr

Volltext

Regional and temporal expression of sodium channel messenger RNAs in the rat brain during development von BRYSCH, W, CREUTZFELDT, O. D, LUNO, K, SCHLINGENSIEPEN, R, SCHLINGENSIEPEN, K.-H

Volltext

The role of transforming growth factor-β in carcinogenesis von Schlingensiepen, Karl Hermann, Fischer-Blass, Birgit, Jachimczak, Piotr, Schlingensiepen, Reimar

Volltext

The role of Jun transcription factor expression and phosphorylation in neuronal differentiation, neuronal cell death, and plastic adaptations in vivo von Schlingensiepen, K H, Wollnik, F, Kunst, M, Schlingensiepen, R, Herdegen, T, Brysch, W

Volltext

The topology of the thalamo-cortical projections in the marmoset monkey (Callithrix jacchus) von BRYSH, W, BRYSH, I, CREUTZFELD, O. D, SCHLINGESIEPEN, R, SCHLINGENSIEPEN, K.-H

Volltext

TGF-β2 suppression by the antisense oligonucleotide AP 12009 as treatment for pancreatic cancer: preclinical efficacy data von Stauder, G., Bischof, A., Egger, T., Hafner, M., Herrmuth, H., Jachimczak, P., Kielmanowicz, M., Schlingensiepen, R., Schlingensiepen, K.-H.

Volltext

TGF-β2 suppression by the antisense oligonucleotide AP 12009 as treatment for pancreatic cancer: preclinical efficacy data von Stauder, G., Bischof, A., Egger, T., Hafner, M., Herrmuth, H., Jachimczak, P., Kielmanowicz, M., Schlingensiepen, R., Schlingensiepen, K.-H.

Volltext

Developmental expression of the transcription factor zif268 in rat brain von Herms, Jochen, Zurmöhle, Uwe, Schlingensiepen, Reimar, Brysch, Wolfgang, Schlingensiepen, Karl-Hermann

Volltext

Changes in the expression of synapsin I and II messenger RNA during postnatal rat brain development von Zurmöhle, U, Herms, J, Schlingensiepen, R, Brysch, W, Schlingensiepen, K H

Volltext

Changes of synapsin I messenger RNA expression during rat brain development von ZURMÖHLE, U.-M, HERMS, J, SCHLINGENSIEPEN, R, SCHLINGENSIEPEN, K.-H, BRYSCH, W

Volltext

Differential expression of c-jun, junB, and junD in rat hippocampal slices von Schlingensiepen, Reimar, Terlau, Heinrich, Brysch, Wolfgang, Schlingensiepen, Karl-Hermann

Volltext

Antisense oligomers for selective suppression of MCP-1 synthesis in human pulmonary endothelial cells von Maus, U A, Herold, S, Schlingensiepen, K H, Schlingensiepen, R, Dormayr, T, Rosseau, S, Maus, R, Seeger, W, Lohmeyer, J

Volltext

449 Treatment of pancreatic cancer by TGF-beta2 suppression mediated by the antisense oligonucleotide AP 12009: preclinical efficacy data von Stauder, G., Bischof, A., Egger, T., Hafner, M., Herrmuth, H., Kielmanocwicz, M., Jachimczak, P., Schlingensiepen, R., Schlingensiepen, K.

Volltext

820 TGF-beta1 suppression by the antisense oligonucleotide AP 11014 as treatment strategy for non-small cell lung cancer and colorectal cancer von Jachimczak, P., Schlingensiepen, K.-H., Schlingensiepen, R., Bischof, A., Graf, K., Hafner, M., Kielmanowicz, M., Szyrach, M., Stauder, G.

Volltext

Cationic lipids employed for antisense oligodeoxynucleotide transport may inhibit vascular cell adhesion molecule-1 expression in human endothelial cells: a word of caution von Maus, U, Rosseau, S, Mandrakas, N, Schlingensiepen, R, Maus, R, Muth, H, Grimminger, F, Seeger, W, Lohmeyer, J

Volltext

Intracerebral and intrathecal infusion of the TGF-beta 2-specific antisense phosphorothioate oligonucleotide AP 12009 in rabbits and primates: toxicology and safety von Schlingensiepen, Reimar, Goldbrunner, Michael, Szyrach, Mara N I, Stauder, Gerhard, Jachimczak, Piotr, Bogdahn, Ulrich, Schulmeyer, Frank, Hau, Peter, Schlingensiepen, Karl-Hermann

Volltext

Changes in the expresion of synapsin I and II messenger RNA during postnatal rat brain development von ZURMÖHLE, U, HERMS, J, SCHLINGENSIEPEN, R, BRYSCH, W, SCHLINGENSIEPEN, K.-H

Volltext

229 Suppression of TGF-beta2 in pancreatic cancer by the antisense oligonucleotide ap 12009: preclinical efficacy data as basis for clinical studies von Stauder, G., Jachimczak, P., Schlingensiepen, R., Goldbrunner, M., Graf, K., Kielmanowicz, M., Hafner, M., Szyrach, M., Bischof, A.

Volltext